West Pharmaceutical ServicesWSTEarnings & Financial Report
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin.
WST Q4 2025 Key Financial Metrics
売上高
$805.0M
粗利益
$303.9M
営業利益
$156.6M
純利益
$132.1M
粗利益率
37.8%
営業利益率
19.5%
純利益率
16.4%
前年比成長
7.5%
EPS
$1.82
資金フロー
West Pharmaceutical Services Q4 2025 Financial Summary
West Pharmaceutical Services reported revenue of $805.0M for Q4 2025, with a net profit of $132.1M (16.4% margin). Cost of goods sold was $501.1M, operating expenses totaled $147.3M.
Key Financial Metrics
| Total Revenue | $805.0M |
|---|---|
| Net Profit | $132.1M |
| Gross Margin | 37.8% |
| Operating Margin | 19.5% |
| Report Period | Q4 2025 |
West Pharmaceutical Services Annual Revenue by Year
West Pharmaceutical Services annual revenue history includes year-by-year totals (for example, 2025 revenue was $3.1B).
| Year | Annual Revenue |
|---|---|
| 2025 | $3.1B |
| 2024 | $2.9B |
| 2023 | $2.9B |
| 2022 | $2.9B |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $695.4M | $702.1M | $746.9M | $748.8M | $698.0M | $766.5M | $804.6M | $805.0M |
| 前年比成長 | -3.0% | -6.9% | -0.1% | 2.3% | 0.4% | 9.2% | 7.7% | 7.5% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $3.60B | $3.49B | $3.68B | $3.64B | $3.62B | $3.95B | $4.11B | $4.27B |
| 総負債 | $921.7M | $912.6M | $923.0M | $961.1M | $935.1M | $1.02B | $1.05B | $1.09B |
| 株主資本 | $2.68B | $2.58B | $2.75B | $2.68B | $2.68B | $2.93B | $3.05B | $3.18B |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $118.2M | $165.0M | $180.1M | $190.1M | $129.4M | $177.1M | $197.2M | $251.1M |
Other Health Care Companies
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B
BAX
Baxter International
売上高
$3.0B
純利益
$-1.1B
BDX
Becton Dickinson
売上高
$5.3B
純利益
$382.0M
TECH
Bio-Techne
売上高
$295.9M
純利益
$38.0M
BIIB
Biogen
売上高
$2.3B
純利益
$-48.9M
BSX
Boston Scientific
売上高
$5.3B
純利益
$670.0M